Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects.
Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies.
Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has nearly 30 years of experience in aptamer selection.
Novaptech selects aptamers against any kind of target : synthetic molecules, peptides, proteins, non pathogenic viruses and bacteria, eukaryotic cells.
We optimize the selected aptamer sequence: truncation to the minimal size, introduction of modifications for improving aptamer properties, conjugation to the appropriate group (thiol, carboxy, amine, fluorophore, etc…) depending on the intended assay (imaging, biosensing, affinity purification, etc…).
We select functional structure switching aptamers based on the Novaptech’s innovative “switch-kiss” technology. This is particularly adapted to the detection of small molecules (contaminants, drugs, biomarkers, nutriments…).
Aptamer applications
Aptamers as therapeutics
Aptamers for diagnostic in human and animal health
Aptamers for analytical purposes, environment & food safety monitoring
Novaptech added-value
Scientist-to-scientist interactions
With Novaptech you benefit from nearly 30 years experience on aptamers. From the very early stage of your project you have a personal contact with one of our senior scientists for evaluating the feasibility, designing the library and the selection procedure, defining the chemical modifications and the assay. Feedback is provided at every step of your project.
Our R&D researchers work on innovative processes for aptamer selection and assay design that are immediately offered to our customers. At Novaptech activity is focused on a particular class of structure-switching aptamers taking advantage of the unique « switch-kiss » technology.
Novaptech has been approved for the Research Tax Credit for years 2020, 2021, 2022, 2023 and 2024. Novaptech customers can benefit from a refundable tax credit for R&D services entrusted to Novaptech.
Eurogentec provides products and services to scientists involved in life science research, molecular diagnostics and therapeutic developments. Expert in small and large-scale synthesis, Eurogentec produces a wide range of custom oligonucleotides from classical primers up to highly complex sequences. Novaptech and Eurogentec signed a partnership for the production of aptamers selected by Novaptech.
Any question about selection service or assay development ? Please fill in the form below with relevant details for helping us providing an informative answer. Telephone call can be arranged. NDA can be signed, would you wish so. We will answer you as quickly as possible (generally less than 2 working days).